Solar Foods is advancing VTT and LUT research as the basis for a wheat flour-like food protein product fermented using water, electricity and CO2.

Illumina Ventures has led a series A1 round for Cernostics, a cancer diagnostics company that has now raised $13m from backers including UPMC Enterprises.

SUNY Downstate spinout Concarlo is working on tests to establish the suitability of breast cancer patients for a therapy known as CDK4 inhibitor treatment.

Qubis has backed Causeway's bid to create a nanochip-powered sensor that would help prevent ineffective antibiotic prescriptions.

The Lund University spinout, which is working on diagnostics technology for applications in oncology, will use the proceeds to pursue a recruitment drive.

The company, led by two UW researchers, remains in stealth but is reportedly working on organism-resistant materials to ward against the threat of infection.